Barry M. Berger, MD, FCAP
Chefarzt
Naveris, Inc.
VERANSTALTUNGEN
Dialog zur Krebsvorbeugung
Discover and discuss the latest advances in research, policy and program best practices in cancer prevention and early detection.
Der Dialog zur Krebsvorbeugung brings together a diverse group of partners to discuss the latest advances in research, policy, practice and programs in cancer prevention and early detection. Experts in the field give timely and enlightening presentations on trending topics with opportunities for discussion and peer-to-peer conversations among participants. Participants take Dialogue learnings back to their communities and workplaces to enhance or expand their work.
2025 Prevent Cancer Dialogue Virtual Series
This series of three 90-minute webinars will feature presentations from experts in the field and moderated discussions with the audience. Continuing education credit will be offered. Registration is free of charge!
- April 2, 2025: Updates on young-onset cancers: What to know and public health implications
- June 4, 2025: Diversifying clinical trial participation: Pathways from screenings to trials
- October 8, 2025: Minimal residue disease (MRD): Exploring the impact of cancer early detection and personalized care
Stay Connected
Receive updates on our Dialog zur Krebsvorbeugung series and other learning opportunities.
Sign UpSpecial thank you to the 2025 Dialogue supporters!
If your organization would like to support the 2025 Prevent Cancer Dialogue, or for more information on how you can become a corporate partner of the Prevent Cancer Foundation, please contact Jennifer Niyangoda at 703-837-3684 or Jennifer.Niyangoda@preventcancer.org.
Lernen Sie die Dialogue Advisory Group kennen
David Berrigan, Ph.D., MPH
Programmdirektor, Verhaltensforschungsprogramm
Nationales Krebs Institut
Melissa Buffalo, MS
Geschäftsführer
Amerikanische Indianer-Krebsstiftung
Gloria D. Coronado, Ph.D.
Ausgezeichneter Forscher, Mitch Greenlick-Stiftungswissenschaftler für gesundheitliche Ungleichheit
Kaiser Permanente
Danielle Grimm, MPH, MSN, CNP, WHNP-BC
Ärztlicher Direktor Gynäkologie
Gemeindegesundheitszentrum Dimock
Nikki Hayes, MPH
Leiter der Abteilung für umfassende Krebsbekämpfung
Center for Disease Control
Kathleen M. Schmeler, MD
Geschäftsführender Direktor, Professor für globale Onkologie, Professor für gynäkologische Onkologie
MD Anderson Krebszentrum
Richard C. Wender, MD
Lehrstuhl für Familienmedizin und öffentliche Gesundheit
Universität von Pennsylvania